Last updated on October 22, 2025
No, it is not allowed. European regulations require that infectious biological samples be packaged and transported in compliance with international standards, including WHO protocols, to ensure safety and legal conformity.
Sealed and Safe: Why Europe Demands WHO Protocols for Infectious Samples
In the high-stakes world of infectious disease control, transporting biological samples isn’t just a logistical task—it’s a matter of public health. And in Europe, the rules are clear: if you’re moving infectious substances, you must follow the packaging protocols set by the World Health Organization (WHO).
The WHO’s guidance on the transport of infectious substances is not just a suggestion—it’s a globally recognized standard. These protocols are designed to prevent leaks, contamination, and exposure during transit. They include the use of the “triple packaging system,” which consists of a leak-proof primary container, a leak-proof secondary container, and a rigid outer packaging. This system is mandatory for all modes of transport, whether by road, rail, air, or sea.
In Europe, these standards are embedded in national and EU-level regulations. The European Medicines Agency (EMA) and the European Commission require compliance with WHO guidelines as part of broader health and safety laws. These rules apply to hospitals, laboratories, research institutions, and logistics companies handling infectious materials.
Legal Framework and Enforcement
Failure to comply with WHO packaging protocols can result in serious consequences. Under EU law, improperly packaged infectious substances may be classified as hazardous goods, triggering penalties under transport and public health regulations. This includes fines, suspension of licenses, and even criminal charges in cases of gross negligence.
The WHO’s 2023–2024 guidance, applicable from October 2023, outlines updated procedures for classifying, identifying, packaging, marking, labeling, and refrigerating infectious substances. It also emphasizes the importance of training and competency for all personnel involved in the transport process.
These protocols are not just about bureaucracy—they’re about safety. A breach in packaging could expose handlers, transport workers, or the public to dangerous pathogens. That’s why European authorities treat compliance as non-negotiable.
Practical Implications
For researchers and healthcare professionals, the rules mean planning ahead. Packaging materials must meet specific standards, documentation must be complete, and carriers must be certified to handle biohazardous materials. Even minor errors—like incorrect labeling or missing documentation—can delay shipments or lead to regulatory action.
The WHO also stresses the importance of coordination between senders, carriers, and receivers. Everyone in the chain must understand the risks and responsibilities involved. In Europe, this collaborative approach is supported by national health agencies and EU-wide training programs.
Why It Matters
Transporting infectious samples is essential for diagnosing diseases, conducting research, and responding to outbreaks. But without proper packaging, the risks outweigh the benefits. Europe’s insistence on WHO protocols reflects a commitment to safety, science, and international cooperation.
So if you’re shipping something that could make people sick, make sure it’s sealed, labeled, and documented to the letter. In Europe, there’s no room for shortcuts.
See more on European Union
Sources
Guidance on regulations for the transport of infectious substances, 2023–2024
https://www.who.int/europe/publications/i/item/9789240089525
March 7, 2025
Guideline on the packaging information of medicinal products for human use
https://health.ec.europa.eu/system/files/2023-09/2018packagingguidelinesen1.pdf
September 2023